OBGYN Flashcards
Levonorgestrel can Be taken
Within seventy two hours of unprotected sexual intercourse
How does uli pristal work
Inhibits Ovulation
When can ullipristal still be taken
No later than a hundred and twenty hours after unprotected intercourse
Big caution for ulliprisyal
Asthms
When can an IUD be used as a form of emergency contraception
Must be inserted within five days of unprotected sexual intercourse
If a woman presents after five days, then an r u d may be fitted up 25 days after the likely ovulation dates ie fourteen days
What is nexplanon
Subdormal contraceptive which slowly releases protester on hormone
Works by preventing ovulation
Adverse effects of nexplanon
A regular or heavy bleeding
Headache nausea breast pain
When is the early scan to confirm dates
10 - 13+6 weeks
When can I u d be relied on for contraception after insertion
Immediately
When can I us be relied upon for contraception following insertion
After seven days
The most significant risk of prescribing an oestrogen-only preparation rather than a combined oestrogen-progestogen preparation is
increased risk of endometrial cancer
COCP UKMEC 3
more than 35 years old and smoking less than 15 cigarettes/day
BMI > 35 kg/m^2*
family history of thromboembolic disease in first degree relatives < 45 years
controlled hypertension
immobility e.g. wheel chair use
carrier of known gene mutations associated with breast cancer (e.g. BRCA1/BRCA2)
current gallbladder disease
COCP UKMEC4
more than 35 years old and smoking more than 15 cigarettes/day
migraine with aura
history of thromboembolic disease or thrombogenic mutation
history of stroke or ischaemic heart disease
breast feeding < 6 weeks post-partum
uncontrolled hypertension
current breast cancer
major surgery with prolonged immobilisation
positive antiphospholipid antibodies (e.g. in SLE)
risks of HRT
Venous thromboembolism: a slight increase in risk with all forms of oral HRT. No increased risk with transdermal HRT.
Stroke: slightly increased risk with oral oestrogen HRT.
Coronary heart disease: combined HRT may be associated with a slight increase in risk.
Breast cancer: there is an increased risk with all combined HRT although the risk of dying from breast cancer is not raised.
Ovarian cancer: increased risk with all HRT.
NICE (2008) advise giving anti-D to non-sensitised Rh -ve mothers at
28 and 34 weeks
Medical management of urge urinary incontinence
antimuscarinics are first-line
NICE recommend oxybutynin (immediate release), tolterodine (immediate release) or darifenacin (once daily preparation)
mirabegron (abeta-3 agonist) may be useful if there is concern about anticholinergic side-effects infrail elderly patients